The research reveals the mechanism behind the most dangerous symptoms caused by hemorrhagic fever viruses
The first clinical trial of the investigational TCR cell therapy began enrolling patients with AML in UK and USA
The layer of sugars surrounding tumor cells plays a key role in hiding and defending them from the immune system
A five years research project led to a better understanding of the mechanisms underlying the disease and will pave the way to new therapeutic strategies
